BPC-157 + TB-500 10mg
This blend pairs BPC-157 with TB-500, the thymosin beta-4 fragment, in equal amounts: 5 mg of each in a 10 mg vial. Both peptides have been studied separately in tissue-repair models; combining them lets a single preparation test whether the two mechanisms interact. Supplied for laboratory research use only. Not for human or veterinary use.
BPC-157 and TB-500 in one vial, at a 1:1 ratio.
This blend pairs BPC-157 with TB-500, the thymosin beta-4 fragment, in equal amounts: 5 mg of each in a 10 mg vial. Both peptides have been studied separately in tissue-repair models; combining them lets a single preparation test whether the two mechanisms interact.
What the research shows
BPC-157 work centres on VEGFR2 activation and nitric-oxide modulation, while TB-500 studies focus on actin polymerisation and cell migration through the LKKTETQ motif.
Giving the two together lets researchers ask whether the distinct mechanisms are additive or synergistic across tissue repair, angiogenesis and inflammatory response.
Why researchers choose Aevryn Labs
Every batch is tested at a leading Australian university, where HPLC and mass spectrometry confirm a purity of 99% or higher. No generic overseas certificates.
Explore the research library
